Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 8;14(5):e0015625.
doi: 10.1128/mra.00156-25. Epub 2025 Apr 15.

Genome sequence of a lytic phage phi1_092060 targeting ST2 KL104-type Acinetobacter baumannii

Li Wei  1   2 , Jiayuan Qin  1 , Yu Feng  3   4 , Zhiyong Zong  1   3   4
Affiliations

Genome sequence of a lytic phage phi1_092060 targeting ST2 KL104-type Acinetobacter baumannii

Li Wei et al. Microbiol Resour Announc. .

Abstract

We describe the genome of a lytic phage isolated from sewage, which is capable of lysing ST2 KL104-type carbapenem-resistant Acinetobacter baumannii strains. The genome is 167,208 bp in length, has a guanine-cytosine (GC) content of 37%, and includes 266 protein-coding sequences and five tRNAs.

Keywords: Acinetobacter baumannii; capsular polysaccharide; carbapenem resistance; phage; phage therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig 1
Fig 1
The morphology of phage phi1_092060 under transmission electron microscopy. The scale was 200 nm.
See this image and copyright information in PMC

References

    1. World Health Organization . 2024. WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance, to guide research, development, and strategies to prevent and control antimicrobial resistance. https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-....
    1. Shields RK, Paterson DL, Tamma PD. 2023. Navigating available treatment options for carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex infections. Clin Infect Dis 76:S179–S193. doi:10.1093/cid/ciad094 - DOI - PMC - PubMed
    1. Iovleva A, Fowler VG, Doi Y. 2025. Treatment approaches for carbapenem-resistant Acinetobacter baumannii infections. Drugs (Abingdon Engl) 85:21–40. doi:10.1007/s40265-024-02104-6 - DOI - PMC - PubMed
    1. Koncz M, Stirling T, Hadj Mehdi H, Méhi O, Eszenyi B, Asbóth A, Apjok G, Tóth Á, Orosz L, Vásárhelyi BM, et al. . 2024. Genomic surveillance as a scalable framework for precision phage therapy against antibiotic-resistant pathogens. Cell 187:5901–5918. doi:10.1016/j.cell.2024.09.009 - DOI - PubMed
    1. Evseev PV, Sukhova AS, Tkachenko NA, Skryabin YP, Popova AV. 2024. Lytic capsule-specific Acinetobacter bacteriophages encoding polysaccharide-degrading enzymes. Viruses 16:771. doi:10.3390/v16050771 - DOI - PMC - PubMed

LinkOut - more resources